IL266938A - Pharmaceutical preparation and method for its manufacture - Google Patents

Pharmaceutical preparation and method for its manufacture

Info

Publication number
IL266938A
IL266938A IL266938A IL26693819A IL266938A IL 266938 A IL266938 A IL 266938A IL 266938 A IL266938 A IL 266938A IL 26693819 A IL26693819 A IL 26693819A IL 266938 A IL266938 A IL 266938A
Authority
IL
Israel
Prior art keywords
manufacture
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
IL266938A
Other languages
English (en)
Hebrew (he)
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of IL266938A publication Critical patent/IL266938A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL266938A 2016-12-09 2019-05-28 Pharmaceutical preparation and method for its manufacture IL266938A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16203308 2016-12-09
PCT/EP2017/081049 WO2018104150A1 (fr) 2016-12-09 2017-11-30 Préparation pharmaceutique et méhode pour sa fabrication

Publications (1)

Publication Number Publication Date
IL266938A true IL266938A (en) 2019-07-31

Family

ID=57544274

Family Applications (1)

Application Number Title Priority Date Filing Date
IL266938A IL266938A (en) 2016-12-09 2019-05-28 Pharmaceutical preparation and method for its manufacture

Country Status (16)

Country Link
US (1) US11382865B2 (fr)
EP (1) EP3551173A1 (fr)
JP (1) JP2020500898A (fr)
KR (1) KR20190093571A (fr)
CN (1) CN110022862B (fr)
AU (1) AU2017370975A1 (fr)
BR (1) BR112019011502A2 (fr)
CA (1) CA3046275A1 (fr)
CL (1) CL2019001555A1 (fr)
CO (1) CO2019005955A2 (fr)
DO (1) DOP2019000157A (fr)
IL (1) IL266938A (fr)
MX (1) MX2019006742A (fr)
PH (1) PH12019501249A1 (fr)
RU (1) RU2764849C2 (fr)
WO (1) WO2018104150A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3114704A1 (fr) * 2018-10-12 2020-04-16 Hovione Scientia Formulations de lactones macrocycliques, leurs methodes de preparation et utilisation des formulations dans le traitement de pathologies secondaires a des parasites ophtalmiques

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5030622A (en) 1989-06-02 1991-07-09 Merck & Co., Inc. Avermectin derivatives
IT1264517B1 (it) 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
DK1197215T3 (da) 2000-10-10 2006-07-10 Wyeth Corp Anthelmintiske sammensætninger
US6893652B2 (en) * 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
IN191024B (fr) * 2001-09-25 2003-09-13 J B Chemicals And Pharmaceutic
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
TWI366442B (en) * 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005084688A1 (fr) * 2004-03-04 2005-09-15 Yuwan Wang Poudre injectable contenant un vermifuge
US20060024368A1 (en) 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
WO2006036624A2 (fr) 2004-09-24 2006-04-06 The Hartz Mountain Corporation Formulations lipidiques stabilisees
US7348027B2 (en) 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
WO2008134819A1 (fr) 2007-05-07 2008-11-13 Jurox Pty Ltd Forme posologique améliorée et procédé associé
US20080293645A1 (en) * 2007-05-25 2008-11-27 Schneider Lawrence F Antiparasitic combination and method for treating domestic animals
DK3351546T5 (da) 2011-12-02 2024-08-12 Boehringer Ingelheim Vetmedica Gmbh Langtidsvirkende injicerbare moxidectinformuleringer
HU231017B1 (hu) * 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
US10543170B2 (en) * 2012-12-19 2020-01-28 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
IN2013MU03583A (fr) 2013-11-14 2015-07-31 Cipla Ltd
JP6957610B2 (ja) * 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ

Also Published As

Publication number Publication date
EP3551173A1 (fr) 2019-10-16
CO2019005955A2 (es) 2019-06-19
WO2018104150A1 (fr) 2018-06-14
CL2019001555A1 (es) 2019-10-25
CA3046275A1 (fr) 2018-06-14
RU2019121235A (ru) 2021-01-12
AU2017370975A1 (en) 2019-05-30
RU2019121235A3 (fr) 2021-02-16
JP2020500898A (ja) 2020-01-16
BR112019011502A2 (pt) 2019-11-05
CN110022862A (zh) 2019-07-16
KR20190093571A (ko) 2019-08-09
DOP2019000157A (es) 2019-07-15
CN110022862B (zh) 2022-05-24
US20200069591A1 (en) 2020-03-05
RU2764849C2 (ru) 2022-01-21
PH12019501249A1 (en) 2019-12-02
MX2019006742A (es) 2019-09-05
US11382865B2 (en) 2022-07-12

Similar Documents

Publication Publication Date Title
HK1255566A1 (zh) 氧代吡啶酰胺類衍生物、其製備方法及其在醫藥上的應用
IL250744A0 (en) A method for preparing flavociclib and its pharmaceutical preparations
GB201817116D0 (en) Pharmaceutical preparation of palbociclic and preparation method thereof
EP3159424A4 (fr) Barre d'armature et son procédé de préparation
GB201702672D0 (en) Chromatographic materail and method for preparation thereof
EP3438105A4 (fr) Composé de diaryl-b-lactame et son procédé de préparation et utilisation pharmaceutique associée
EP3093296A4 (fr) Oligo-glycosaminoglycane fuc3s4s substitué et son procédé de préparation
ZA201703398B (en) Pharmaceutical composition and methods
EP3137204C0 (fr) Systeme et procédé pour préparer des compositions de pharmacie pour les ordonnances individuelles
EP3398615A4 (fr) Composition pharmaceutique mucoadhésive et son procédé de préparation
PL3391893T3 (pl) Kompozycja farmaceutyczna do leczenia białaczki i sposób jej przygotowania
LT3256154T (lt) Farmacinė kompozicija, apimanti antikūną
HK1214767A1 (zh) 片劑形式的藥物組合物及其製造方法
EP3424521A4 (fr) Composition pharmaceutique et son procédé de fabrication
ZA201608720B (en) Thermobaric nonel and preparation method thereof
ZA201908090B (en) Pharmaceutical composition and method for preparing same
HUE060710T2 (hu) Aprepitantot tartalmazó gyógyszerkészítmény és eljárás annak elõállítására
HK1258861A1 (zh) 配製藥物製劑的方法和裝置
PT2957280T (pt) Composição farmacêutica sólida de citisina e processo para a sua preparação
IL253174B (en) Nano-particles and methods for their preparation
IL266938A (en) Pharmaceutical preparation and method for its manufacture
EP3305283A4 (fr) Composition pharmaceutique stabilisée et son procédé de préparation
EP3563846A4 (fr) Composition médicinale, et procédé de fabrication de celle-ci
EP3251672A4 (fr) Composition pharmaceutique et procédé de préparation de cette dernière
PT3383402T (pt) Composição farmacêutica compreendendo darunavir e método para a sua preparação